Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
Eisai Inc. Eisai Limited |
---|---|
Information provided by: | Eisai Medical Research Inc. |
ClinicalTrials.gov Identifier: | NCT00280410 |
This is a multicenter, randomized, open-label study to investigate the superiority of the contrast enhancement effect of E7337 on tumor-like lesions in the Dynamic CT of the liver.
Condition | Intervention | Phase |
---|---|---|
Lesions of the Liver |
Drug: E7337 |
Phase II Phase III |
Study Type: | Interventional |
Study Design: | Diagnostic, Randomized, Open Label, Dose Comparison, Parallel Assignment, Efficacy Study |
Official Title: | Multicenter, Randomized, Open-Label Study Investigating The Superiority Of The Contrast Enhancement Effect Of E7337 On Tumor Like Lesion In The Dynamic CT Of The Liver Of Patients With Tumor Like Lesions In The Liver |
Estimated Enrollment: | 192 |
Study Start Date: | January 2006 |
Ages Eligible for Study: | 20 Years to 80 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:Issues affecting the safety evaluation of the investigational agent:
General concerns relating to the safety of the subject:
Japan | |
Fukuoka, Japan, 810-0065 | |
Fukushima, Japan | |
Kumamoto, Japan | |
Okayama, Japan | |
Japan, Hokkaido | |
Sapporo, Hokkaido, Japan | |
Japan, Hyogo | |
Kobe, Hyogo, Japan | |
Japan, Ishikawa | |
Kanazawa, Ishikawa, Japan | |
Japan, Kanagawa | |
Isehara, Kanagawa, Japan | |
Japan, Nara | |
Kashihara, Nara, Japan | |
Japan, Osaka | |
Osakasayama, Osaka, Japan | |
Suita, Osaka, Japan | |
Japan, Tokyo | |
Shinagawa-ku, Tokyo, Japan | |
Shinjuku-ku, Tokyo, Japan | |
Minato-ku, Tokyo, Japan |
Study Director: | Koichi Tazawa | Eisai Company Lmited |
Study ID Numbers: | E7337-J081-151 |
Study First Received: | January 20, 2006 |
Last Updated: | September 25, 2008 |
ClinicalTrials.gov Identifier: | NCT00280410 History of Changes |
Health Authority: | Japan: Ministry of Health, Labor and Welfare |